An expert insight into fatty liver disease

Written by: Professor Emmanouil Tsochatzis
Published:
Edited by: Carlota Pano

Fatty liver disease is the most common cause of liver disease, affecting an estimated 1 in 4 people in the UK.

 

Here to provide an expert insight into fatty liver disease, including causes, diagnosis and treatment, is Professor Emmanouil Tsochatzis, renowned consultant hepatologist in London.

 

 

What is fatty liver disease, and what is the difference between non-alcohol fatty liver disease and alcohol-related liver disease?

 

Fatty liver disease is a condition characterised by the accumulation of fat in the liver cells. This can compromise liver function over time, causing complications.

 

There are two types of fatty liver disease:

  • Non-alcoholic fatty liver disease (NAFLD): Linked to metabolic factors such as obesity and diabetes. NAFLD can progress from simple fatty liver disease to non-alcoholic steatohepatitis, involving inflammation and potential damage to the liver.
  • Alcohol-related liver disease (ALD): Linked to excessive and prolonged alcohol intake. ALD can lead to inflammation and ultimately, cirrhosis.

 

How is fatty liver disease detected and diagnosed?

 

Fatty liver disease is often asymptomatic in its early stages.

 

As fatty liver disease progresses, people may experience the following symptoms:

  • persistent weakness and fatigue
  • discomfort in the upper right side of the abdomen

 

Once cirrhosis develops, people may experience:

 

Diagnosing fatty liver disease involves a combination of medical history, physical examination, and diagnostic tests.

 

Common diagnostic tests include:

  • Blood tests: Liver function tests measure the levels of liver enzymes and other substances in the blood. Elevated liver enzymes may indicate liver inflammation or liver damage.
  • Imaging studies: Ultrasound, CT scans, and MRI scans can provide detailed images of the liver, helping to assess liver health.
  • FibroScan®: FibroScan® is a non-invasive test to measure liver stiffness, helping to assess the degree of fibrosis or cirrhosis.
  • Liver biopsy: In some cases, a small sample of liver tissue may be obtained for microscopic examination to determine the extent of the liver damage.

 

Early diagnosis is crucial for the effective management of fatty liver disease, allowing for timely intervention to prevent the progression of the condition.

 

What lifestyle modifications, including diet and exercise, are effective for managing fatty liver disease?

 

Adopting a healthy lifestyle is the bottom line for managing fatty liver disease.

 

Key lifestyle modifications include:

  • Weight management: Losing 10 per cent of excess weight, especially around the abdominal area, can significantly improve liver health.
  • A balanced diet: A diet rich in fruits, vegetables, whole grains, and lean proteins is beneficial for liver health. Avoiding sugary foods, refined carbohydrates, and excessive saturated fats is essential.
  • Regular exercise: Regular physical activity helps with weight management and also improves insulin sensitivity. Patients should aim for at least 150 minutes of moderate-intensity exercise per week.
  • Limited alcohol intake: Limited or complete abstinence from alcohol is required.
  • Control of diabetes and cholesterol levels: Keeping diabetes under control and maintaining healthy cholesterol levels contributes to overall liver health.

 

When is a liver transplant considered?

 

In serious cases of end-stage liver disease, where fatty liver disease has progressed to cirrhosis and the liver has sustained irreversible damage, a liver transplant may be considered. Liver transplantation involves replacing a damaged liver with a healthy liver from a donor.

 

 

If you require expert diagnosis and treatment for fatty liver disease, don’t hesitate to book an appointment with Professor Emmanouil Tsochatzis via his Top Doctors profile today.

By Professor Emmanouil Tsochatzis
Hepatology (liver specialist)

Professor Emmanouil Tsochatzis is a distinguished consultant hepatologist based in London, whose work in fatty liver and cirrhosis is internationally renowned.

Professor Tsochatzis, who consults privately at The Royal Free Hospital and at Platinum Medical Centre, originally qualified from the National and Kapodistrian University of Athens. He undertook his hepatology training at the prestigious Hippokration General Hospital in Athens, and also obtained a PhD, before joining The Royal Free Hospital to complete his post-doctorate research. He was subsequently appointed as a Senior Clinical Lecturer in UCL and a Consultant at the Royal Free Hospital.

Professor Tsochatzis has a special interest in fatty liver disease, cirrhosis and complications, metabolic liver disease (including Wilson’s disease and heamochromatosis) and non-invasive fibrosis assessment. He has set up pathways for the early detection of liver disease and Liver Health checks in people at risk of liver fibrosis. He currently leads the specialist multidisciplinary service for non-alcoholic fatty liver disease (NAFLD) at the UCL Institute for Liver and Digestive Health.

Professor Tsochatzis' reputation in the field of hepatology extends beyond clinical practice, holding key positions in national and international clinical guideline committees, being a specialist advisor to The National Institute for Health and Care Excellence and the North Thames Hepatology lead for the National Institute for Health Research. He is an expert advisor for the WHO and has participated in the guidelines for the management of HBV and HCV in resource-limited settings. Notably, he served as a member of the governing board of the European Association for the Study of the Liver from 2019 to 2022, and was also the appointed chair of the scientific committee from 2021 to 2022. He has won the prestigious Rising Star award by the United European Gastroenterology in 2014 and the Physician Scientist Fellowship by the European Association for the Study of the Liver.

As a clinician, Professor Tsochatzis is passionate about helping to improve patient outcomes for liver disease, and has led a number of international research collaborations in hepatology which have resulted in the publication of over 300 articles in high-impact, scientific peer-reviewed journals. He is the principal investigator for a number of investigator-led and commercial phase 2 and 3 clinical trials in therapies for fatty liver and cirrhosis and for the early detection of liver fibrosis. In the realm of academia, Professor Tsochatzis is a professor of hepatology and the head of the Centre for Metabolic Liver Disease at University College London.

View Profile

Overall assessment of their patients


  • Related procedures
  • Gastroscopy
    Endoscopy
    Colonoscopy
    Fatty liver
    Gallstones
    Liver surgery
    Jaundice
    Abdominal pain
    Cirrhosis
    Liver biopsy
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.